In an in vivo setting, the knockdown of Cool-1 substantially impedes the tumor-forming capabilities of GBM cells, which is closely associated with the alterations in c-CBL (Stevens et al., 2014). The gene discussed is ARHGEF7; the disease is glioblastoma.